KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Current Deferred Revenue (2018 - 2023)

Tenet Healthcare (THC) has disclosed Current Deferred Revenue for 5 consecutive years, with $86.0 million as the latest value for Q3 2023.

  • For Q3 2023, Current Deferred Revenue fell 22.52% year-over-year to $86.0 million; the TTM value through Sep 2023 reached $86.0 million, down 22.52%, while the annual FY2022 figure was $110.0 million, 87.44% down from the prior year.
  • Current Deferred Revenue hit $86.0 million in Q3 2023 for Tenet Healthcare, up from $76.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.3 billion in Q2 2020 and bottomed at $56.0 million in Q4 2020.
  • Average Current Deferred Revenue over 5 years is $287.6 million, with a median of $98.0 million recorded in 2021.
  • On a YoY basis, Current Deferred Revenue climbed as much as 1677.59% in 2021 and fell as far as 91.63% in 2021.
  • Tenet Healthcare's Current Deferred Revenue stood at $72.0 million in 2019, then dropped by 22.22% to $56.0 million in 2020, then skyrocketed by 1464.29% to $876.0 million in 2021, then plummeted by 87.44% to $110.0 million in 2022, then dropped by 21.82% to $86.0 million in 2023.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $86.0 million, $76.0 million, and $76.0 million for Q3 2023, Q2 2023, and Q1 2023 respectively.